Trials & Litigation
Fosamax Cases Build Against Merck
Posted Jan 30, 2008, 11:04 am CST
By Debra Cassens Weiss
Merck & Co. is facing an increasing number of lawsuits over its osteoporosis drug Fosamax, even as it has announced a possible $4.85 billion settlement of claims related to its painkiller Vioxx.
The roughly 340 Fosamax suits filed as of Sept. 30 claim the drug can cause a bone-wasting condition known as osteonecrosis of the jaw, as well as joint pain and bone fractures, the Wall Street Journal reports (sub. req.). The company has set aside $48 million in reserves for the litigation.
Merck maintains its drug label already warns patients of pain and there is no evidence of increased fractures in those who take the drug.
Related Stories
- DA in Cheney-Gonzales Case Shouts at Judge, Who Seeks Higher-Court Backup
Nov 21, 2008, 06:01 pm CST - Lathrop & Gage to Open Calif. Office By Merging With Spillane Trial Boutique
Nov 21, 2008, 05:26 pm CST - Kansas City, Mo., Mayor Sues After His Wife is Banned from City Hall
Nov 21, 2008, 04:24 pm CST - Graduate of Non-ABA-Accredited Law School Can Take Massachusetts Bar Exam
Nov 21, 2008, 02:26 pm CST
Related Topics
Commenting is not available in this weblog entry.
Comments
Be the first to comment.